Cardiovascular disease is one of many reverberating ailments that affect and kill hundreds
of thousands of people around the world. To date treatments that offer improvement in the …

Cardiovascular diseases (CVDs) represent the most important epidemic of our century, with
more than 37 million patients globally. Furthermore, CVDs are associated with high …

Nanotechnology is poised to have an increasing impact on cardiovascular health in coming
years. Diagnostically, multiplexed point‐of‐care devices will enable rapid genotyping and …

Cardiovascular disease (CVD) encompasses all pathologies of the heart or circulatory
system, including coronary heart disease, peripheral vascular disease and stroke …

Worldwide, cardiovascular diseases (CVDs) account for the vast majority of deaths and
place enormous financial strains on healthcare systems. Gold nanoparticles, quantum dots …

Recent years brought about a widespread interest in the potential applications of
nanotechnology for the diagnostics and the therapy of human diseases. With its promise of …

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide.
Although a cadre of therapeutic strategies have been made available for CVDs in the clinical …

Cardiovascular diseases claim a number of lives globally; many of which are preventable.
With the increase in diets that consist of high saturated fat, salt, and sugar, people often …

Cardiovascular diseases (CVD) account for nearly half of all deaths in Europe and almost
30% of global deaths. Despite the improved clinical management, cardiovascular mortality is …

Cardiovascular diseases (CVDs) are one of the most important causes of mortality and
affecting the health status of patients. At the same time, CVDs cause a huge health and …